 |
The Journal of Neuroscience, May 19, 2004, 24(20):4849-4858; doi:10.1523/JNEUROSCI.0123-04.2004
Previous Article | Next Article 
Cellular/Molecular
Efficient T-Cell Surveillance of the CNS Requires Expression of the CXC Chemokine Receptor 3
Jeanette Erbo Christensen,1
Anneline Nansen,1
Torben Moos,2
Bao Lu,3
Craig Gerard,3
Jan Pravsgaard Christensen,1 and
Allan Randrup Thomsen1
1Institute of Medical Microbiology and Immunology and 2Department of Medical Anatomy, University of Copenhagen, Copenhagen, Denmark, and 3Ina Sue Perlmutter Laboratory, Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115
T-cells play an important role in controlling viral infections inside the CNS. To study the role of the chemokine receptor CXCR3 in the migration and positioning of virus-specific effector T-cells within the brain, CXCR3-deficient mice were infected intracerebrally with lymphocytic choriomeningitis virus (LCMV). Analysis of the induction phase of the antiviral CD8+ T-cell response did not reveal any immune defects in CXCR3-deficient mice. Yet, when mice were challenged with LCMV intracerebrally, most CXCR3-deficient mice survived the infection, whereas wild-type mice invariably died from CD8+ T-cell-mediated immunopathology. Quantitative analysis of the cellular infiltrate in CSF of infected mice revealed modest, if any, decrease in the number of mononuclear cells recruited to the meninges in the absence of CXCR3. However, immunohistological analysis disclosed a striking impairment of CD8+ T-cells from CXCR3-deficient mice to migrate from the meninges into the outer layers of the brain parenchyma despite similar localization of virus-infected target cells. Reconstitution of CXCR3-deficient mice with wild-type CD8+ T-cells completely restored susceptibility to LCMV-induced meningitis. Thus, taken together, our results strongly point to a critical role for CXCR3 in the positioning of effector T-cells at sites of viral inflammation in the brain.
Key words: viral infection; immunopathology; chemokines; CXCR3; T-cells; knock-out mice
Received Jan 13, 2004;
revised April 2, 2004;
accepted April 5, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
J. E. Christensen, S. Simonsen, C. Fenger, M. R. Sorensen, T. Moos, J. P. Christensen, B. Finsen, and A. R. Thomsen
Fulminant Lymphocytic Choriomeningitis Virus-Induced Inflammation of the CNS Involves a Cytokine-Chemokine-Cytokine-Chemokine Cascade
J. Immunol.,
January 15, 2009;
182(2):
1079 - 1087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Thomsen
Lymphocytic Choriomeningitis Virus-Induced Central Nervous System Disease: a Model for Studying the Role of Chemokines in Regulating the Acute Antiviral CD8+ T-Cell Response in an Immune-Privileged Organ
J. Virol.,
January 1, 2009;
83(1):
20 - 28.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Dejnirattisai, T. Duangchinda, C.-L. S. Lin, S. Vasanawathana, M. Jones, M. Jacobs, P. Malasit, X.-n. Xu, G. Screaton, and J. Mongkolsapaya
A Complex Interplay among Virus, Dendritic Cells, T Cells, and Cytokines in Dengue Virus Infections
J. Immunol.,
November 1, 2008;
181(9):
5865 - 5874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Zhang, Y. K. Chan, B. Lu, M. S. Diamond, and R. S. Klein
CXCR3 Mediates Region-Specific Antiviral T Cell Trafficking within the Central Nervous System during West Nile Virus Encephalitis
J. Immunol.,
February 15, 2008;
180(4):
2641 - 2649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Miu, A. J. Mitchell, M. Muller, S. L. Carter, P. M. Manders, J. A. McQuillan, B. M. Saunders, H. J. Ball, B. Lu, I. L. Campbell, et al.
Chemokine Gene Expression during Fatal Murine Cerebral Malaria and Protection Due to CXCR3 Deficiency
J. Immunol.,
January 15, 2008;
180(2):
1217 - 1230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Holst, C. Orskov, K. Qvortrup, J. P. Christensen, and A. R. Thomsen
CCR5 and CXCR3 Are Dispensable for Liver Infiltration, but CCR5 Protects against Virus-Induced T-Cell-Mediated Hepatic Steatosis
J. Virol.,
September 15, 2007;
81(18):
10101 - 10112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Muller, S. L. Carter, M. J. Hofer, P. Manders, D. R. Getts, M. T. Getts, A. Dreykluft, B. Lu, C. Gerard, N. J. C. King, et al.
CXCR3 Signaling Reduces the Severity of Experimental Autoimmune Encephalomyelitis by Controlling the Parenchymal Distribution of Effector and Regulatory T Cells in the Central Nervous System
J. Immunol.,
September 1, 2007;
179(5):
2774 - 2786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Walsh, R. A. Edwards, K. M. Romero, M. V. Kotlajich, S. A. Stohlman, and T. E. Lane
Expression of CXC Chemokine Ligand 10 from the Mouse Hepatitis Virus Genome Results in Protection from Viral-Induced Neurological and Liver Disease
J. Immunol.,
July 15, 2007;
179(2):
1155 - 1165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Hansen, N. J. Bernard, C. Q. Nie, and L. Schofield
NK Cells Stimulate Recruitment of CXCR3+ T Cells to the Brain during Plasmodium berghei-Mediated Cerebral Malaria
J. Immunol.,
May 1, 2007;
178(9):
5779 - 5788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. N. Stiles, J. L. Hardison, C. S. Schaumburg, L. M. Whitman, and T. E. Lane
T Cell Antiviral Effector Function Is Not Dependent on CXCL10 Following Murine Coronavirus Infection
J. Immunol.,
December 15, 2006;
177(12):
8372 - 8380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Babcock, M. Wirenfeldt, T. Holm, H. H. Nielsen, L. Dissing-Olesen, H. Toft-Hansen, J. M. Millward, R. Landmann, S. Rivest, B. Finsen, et al.
Toll-Like Receptor 2 Signaling in Response to Brain Injury: An Innate Bridge to Neuroinflammation
J. Neurosci.,
December 6, 2006;
26(49):
12826 - 12837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-F. Hsieh, S.-L. Lai, J.-P. Chen, J.-M. Sung, Y.-L. Lin, B. A. Wu-Hsieh, C. Gerard, A. Luster, and F. Liao
Both CXCR3 and CXCL10/IFN-Inducible Protein 10 Are Required for Resistance to Primary Infection by Dengue Virus
J. Immunol.,
August 1, 2006;
177(3):
1855 - 1863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Christensen, C. de Lemos, T. Moos, J. P. Christensen, and A. R. Thomsen
CXCL10 Is the Key Ligand for CXCR3 on CD8+ Effector T Cells Involved in Immune Surveillance of the Lymphocytic Choriomeningitis Virus-Infected Central Nervous System
J. Immunol.,
April 1, 2006;
176(7):
4235 - 4243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Storm, C. Bartholdy, M. R. Sorensen, J. P. Christensen, and A. R. Thomsen
Perforin-Deficient CD8+ T Cells Mediate Fatal Lymphocytic Choriomeningitis despite Impaired Cytokine Production
J. Virol.,
February 1, 2006;
80(3):
1222 - 1230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Klein, E. Lin, B. Zhang, A. D. Luster, J. Tollett, M. A. Samuel, M. Engle, and M. S. Diamond
Neuronal CXCL10 Directs CD8+ T-Cell Recruitment and Control of West Nile Virus Encephalitis
J. Virol.,
September 1, 2005;
79(17):
11457 - 11466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. de Lemos, J. E. Christensen, A. Nansen, T. Moos, B. Lu, C. Gerard, J. P. Christensen, and A. R. Thomsen
Opposing Effects of CXCR3 and CCR5 Deficiency on CD8+ T Cell-Mediated Inflammation in the Central Nervous System of Virus-Infected Mice
J. Immunol.,
August 1, 2005;
175(3):
1767 - 1775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Lee, F. Giannoni, A. Lyon, S. Yada, B. Lu, C. Gerard, and S. R. Sarawar
Role of CXCR3 in the Immune Response to Murine Gammaherpesvirus 68
J. Virol.,
July 15, 2005;
79(14):
9351 - 9355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Chen, N. Khanna, S. A. Stohlman, and C. C. Bergmann
Virus-Specific and Bystander CD8 T Cells Recruited during Virus-Induced Encephalomyelitis
J. Virol.,
April 15, 2005;
79(8):
4700 - 4708.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|